His father passed away due to colorectal cancer, and subsequently, he, his biological sibling, and his child also developed the same cancer. He was the first to be free from cancer and has survived 10 years after using ECCT without chemotherapy. He encouraged his sibling and child to also use ECCT without chemotherapy.
他的父亲因结直肠癌去世，随后，他、他的生物兄弟姐妹和他的孩子也患上了同样的癌症。他是第一个摆脱癌症并在使用ECCT而没有化疗的情况下存活了10年。他鼓励他的兄弟姐妹和孩子也使用ECCT而不是化疗。In early 2014, Mr. Ismanto, before his 42nd birthday, was diagnosed with colorectal cancer. The fear he had experienced all along became a reality. Previously, his father died from the same cancer. Now, he himself was afflicted with the disease that had killed his biological father.
2014年初，伊斯曼托先生在42岁生日之前被诊断患有结直肠癌。他长久以来所经历的恐惧变成了现实。此前，他的父亲就因为同样的癌症去世了。现在，他自己也患上了杀死他生物父亲的疾病。Initially, he complained of not being able to have a bowel movement for several days. His abdomen enlarged due to fecal matter accumulating in his colon. A CT scan revealed a blockage in the transverse colon. Suspected fecal fluid filled his intestines, bulging and occupying most of his abdominal cavity. The biopsy results indicated malignancy: poorly differentiated adenocarcinoma. The most aggressive type of colon cancer.
最初，他抱怨几天无法排便。他的腹部因结肠内粪便积聚而变大。CT扫描显示横结肠阻塞。疑似粪便液充满了他的肠道，凸出并占据了他的腹腔大部分空间。活检结果显示恶性：差分不良腺癌。最具侵袭性的结肠癌类型。Because he couldn't have a bowel movement, he had to undergo surgery to remove a 35 cm segment of his colon. Fortunately, his intestines could still be reconnected, so he didn't need a colostomy bag attached to the outside of his abdomen, which would have to be carried around for the rest of his life. The pathology analysis results of the cells removed during Mr. Ismanto's surgery were even more worrying when it shows a second type of cells: High Grade Malignant Fibrohistocytoma. A type of sarcoma located in the colon, more aggressive than adenocarcinoma.
由于他无法排便，他不得不接受手术切除他的结肠35厘米的一段。幸运的是，他的肠道仍然可以重新连接，所以他不需要一个连接在腹部外的结肠造口袋，这意味着他将不得不一辈子带在身上。在伊斯曼托先生手术中取出的细胞的病理分析结果更加令人担忧，显示第二种细胞类型：高级恶性纤维组织细胞瘤。一种位于结肠的肉瘤，比腺癌更具侵袭性。A month after the surgery, the area around Mr. Ismanto's abdomen began to harden again. His cancer was growing back rapidly. In early 2014, Mr. Ismanto made up his mind to use ECCT. The type of cancer Mr. Ismanto had responded relatively quickly to ECCT, both the poorly differentiated adenocarcinoma and the sarcoma types. Both are very aggressive types, but the more aggressive the cancer, the faster the cells respond to the ECCT device, causing them to disintegrate (breaking down into dead cells that liquefy) and exit the body in the form of mucus along with feces.
手术后一个月，伊斯曼托先生的腹部周围开始再次硬化。他的癌症在迅速复发。2014年初，伊斯曼托先生下定决心使用ECCT。伊斯曼托先生患有的癌症类型对ECCT的反应相对迅速，包括差分不良腺癌和肉瘤类型。这两种都是非常侵袭性的类型，但是癌症越具侵袭性，细胞对ECCT设备的反应就越快，导致它们分解（分解为液化的死细胞）并以粘液和粪便的形式排出体外。10 years later, at the beginning of 2024, his condition remained perfectly fine, very healthy, very normal. He never underwent the chemotherapy. He used the ECCT device for 2-3 years and 10 years later, he is still alive and living well.
10年后，2024年初，他的情况依然完全正常，非常健康，非常正常。他从未接受过化疗。他最初使用ECCT设备只有2-3年的时间，10年后，他仍然健在。In 2024, Mr. Ismanto came to consult for two people at once, his biological sister and his biological son. Both have experienced the same cancer as him and his father, colorectal cancer. Both have undergone surgery. Mr. Ismanto wants both of them to be free from cancer like him. His sister and son have been using the device for few months. We hope both of them will be as healthy as him too.
2024年，伊斯曼托先生一次性咨询了两个人，他的生物姐妹和他的生物儿子。他们都经历了和他和他的父亲一样的癌症，结直肠癌。他们都接受了手术。伊斯曼托先生希望他们两个都像他一样摆脱癌症。他的姐妹和儿子已经使用了几个月的ECCT设备。我们希望他们两个都能像他一样健康。
Kommentare